PITTSFORD, NY--(Marketwire - February 27, 2008) - Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation biomedical technology, today announced the appointment of Jeanne Lesniak as one of two advisors for Regulatory and Clinical Affairs for Myotech, LLC, effective immediately. Myotech is a majority-owned subsidiary of Biophan Technologies, Inc.
